Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:40 pm Sale | 2024-12-31 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 0 0.000% | -2,500,000 (Position Closed) | Filing History |
| 2024-11-14 6:59 pm Purchase | 2024-09-30 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 2,500,000 8.900% | 499,540 (+24.97%) | Filing History |
| 2024-11-13 4:06 pm Purchase | 2024-09-30 | 13G | NextCure, Inc. NXTC | Affinity Asset Advisors LLC | 2,302,598 8.220% | 629,759 (+37.65%) | Filing History |
| 2024-06-27 4:47 pm Purchase | 2024-06-20 | 13G | NextCure, Inc. NXTC | Affinity Asset Advisors LLC | 1,672,839 5.980% | 1,672,839 (New Position) | Filing History |
| 2024-04-01 6:34 pm Purchase | 2024-04-01 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 2,000,460 7.200% | 2,000,460 (New Position) | Filing History |
| 2024-03-08 4:34 pm Sale | 2024-03-06 | 13D | NextCure, Inc. NXTC | ORBIMED ADVISORS LLC | 1,268,013 4.500% | -1,443,000 (-53.23%) | Filing History |
| 2024-01-19 4:26 pm Sale | 2023-12-31 | 13G | NextCure, Inc. NXTC | Millennium Management LLC | 1,140,389 4.100% | -309,496 (-21.35%) | Filing History |
| 2023-02-06 3:02 pm Sale | 2022-12-31 | 13G | NextCure, Inc. NXTC | Lilly Asia Ventures Fund III L.P. | 0 0.000% | -1,704,391 (Position Closed) | Filing History |
| 2023-01-24 4:23 pm Purchase | 2023-01-19 | 13G | NextCure, Inc. NXTC | Millennium Management LLC | 1,449,885 5.200% | 1,449,885 (New Position) | Filing History |
| 2022-02-09 12:20 pm Sale | 2021-12-31 | 13G | NextCure, Inc. NXTC | Lilly Asia Ventures Fund III L.P. | 1,704,391 6.200% | -384,468 (-18.41%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | NextCure, Inc. NXTC | BlackRock Inc. BLK | 1,204,689 3.200% | -309,954 (-20.46%) | Filing History |
| 2021-05-10 4:04 pm Sale | 2021-04-30 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 399,919 1.400% | -1,781,699 (-81.67%) | Filing History |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | NextCure, Inc. NXTC | Great Point Partners, LLC | 0 0.000% | -1,376,532 (Position Closed) | Filing History |
| 2021-02-12 10:11 am Sale | 2020-12-31 | 13G | NextCure, Inc. NXTC | LORD, ABBETT & CO. LLC | 0 0.000% | -1,442,300 (Position Closed) | Filing History |
| 2021-02-11 2:11 pm Purchase | 2020-12-31 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 2,181,618 7.900% | 302,638 (+16.11%) | Filing History |
| 2021-02-03 2:52 pm Sale | 2020-12-31 | 13G | NextCure, Inc. NXTC | CANAAN X L.P. | 838,442 3.000% | -1,416,000 (-62.81%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | NextCure, Inc. NXTC | BlackRock Inc. BLK | 1,514,643 5.500% | 1,514,643 (New Position) | Filing History |
| 2020-10-26 4:02 pm Purchase | 2020-10-15 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 1,878,980 6.800% | 1,878,980 (New Position) | Filing History |